Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?
Abstract Background The current target oxygen saturation range for patients with COVID-19 recommended by the National Institutes of Health is 92–96%. Main body This article critically examines the evidence guiding current target oxygen saturation recommendation for COVID-19 patients, and raises impo...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12916-020-01735-2 |
id |
doaj-655eb7217a7941549e675d844261e671 |
---|---|
record_format |
Article |
spelling |
doaj-655eb7217a7941549e675d844261e6712020-11-25T03:54:34ZengBMCBMC Medicine1741-70152020-08-011811610.1186/s12916-020-01735-2Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?Niraj Shenoy0Rebecca Luchtel1Perminder Gulani2Department of Medicine (Oncology), Albert Einstein College of Medicine, Montefiore Medical CenterDepartment of Medicine (Oncology), Albert Einstein College of Medicine, Montefiore Medical CenterDepartment of Medicine (Critical Care Medicine), Albert Einstein College of Medicine, Jacobi Medical CenterAbstract Background The current target oxygen saturation range for patients with COVID-19 recommended by the National Institutes of Health is 92–96%. Main body This article critically examines the evidence guiding current target oxygen saturation recommendation for COVID-19 patients, and raises important concerns in the extrapolation of data from the two studies stated to be guiding the recommendation. Next, it examines the influence of hypoxia on upregulation of ACE2 (target receptor for SARS-CoV-2 entry) expression, with supporting transcriptomic analysis of a publicly available gene expression profile dataset of human renal proximal tubular epithelial cells cultured in normoxic or hypoxic conditions. Finally, it discusses potential implications of specific clinical observations and considerations in COVID-19 patients on target oxygen saturation, such as diffuse systemic endothelitis and microthrombi playing an important pathogenic role in the wide range of systemic manifestations, exacerbation of hypoxic pulmonary vasoconstriction in the setting of pulmonary vascular endothelitis/microthrombi, the phenomenon of “silent hypoxemia” with some patients presenting to the hospital with severe hypoxemia disproportional to symptoms, and overburdened health systems and public health resources in many parts of the world with adverse implications on outpatient monitoring and early institution of oxygen supplementation. Conclusions The above factors and analyses, put together, call for an urgent exploration and re-evaluation of target oxygen saturation in COVID-19 patients, both in the inpatient and outpatient settings. Until data from such trials become available, where possible, it may be prudent to target an oxygen saturation at least at the upper end of the recommended 92–96% range in COVID-19 patients both in the inpatient and outpatient settings (in patients that are normoxemic at pre-COVID baseline). Home pulse oximetry, tele-monitoring, and earlier institution of oxygen supplementation for hypoxemic COVID-19 outpatients could be beneficial, where public health resources allow for their implementation.http://link.springer.com/article/10.1186/s12916-020-01735-2SARS-CoV-2COVID-19HypoxemiaHypoxiaACE2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Niraj Shenoy Rebecca Luchtel Perminder Gulani |
spellingShingle |
Niraj Shenoy Rebecca Luchtel Perminder Gulani Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? BMC Medicine SARS-CoV-2 COVID-19 Hypoxemia Hypoxia ACE2 |
author_facet |
Niraj Shenoy Rebecca Luchtel Perminder Gulani |
author_sort |
Niraj Shenoy |
title |
Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? |
title_short |
Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? |
title_full |
Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? |
title_fullStr |
Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? |
title_full_unstemmed |
Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? |
title_sort |
considerations for target oxygen saturation in covid-19 patients: are we under-shooting? |
publisher |
BMC |
series |
BMC Medicine |
issn |
1741-7015 |
publishDate |
2020-08-01 |
description |
Abstract Background The current target oxygen saturation range for patients with COVID-19 recommended by the National Institutes of Health is 92–96%. Main body This article critically examines the evidence guiding current target oxygen saturation recommendation for COVID-19 patients, and raises important concerns in the extrapolation of data from the two studies stated to be guiding the recommendation. Next, it examines the influence of hypoxia on upregulation of ACE2 (target receptor for SARS-CoV-2 entry) expression, with supporting transcriptomic analysis of a publicly available gene expression profile dataset of human renal proximal tubular epithelial cells cultured in normoxic or hypoxic conditions. Finally, it discusses potential implications of specific clinical observations and considerations in COVID-19 patients on target oxygen saturation, such as diffuse systemic endothelitis and microthrombi playing an important pathogenic role in the wide range of systemic manifestations, exacerbation of hypoxic pulmonary vasoconstriction in the setting of pulmonary vascular endothelitis/microthrombi, the phenomenon of “silent hypoxemia” with some patients presenting to the hospital with severe hypoxemia disproportional to symptoms, and overburdened health systems and public health resources in many parts of the world with adverse implications on outpatient monitoring and early institution of oxygen supplementation. Conclusions The above factors and analyses, put together, call for an urgent exploration and re-evaluation of target oxygen saturation in COVID-19 patients, both in the inpatient and outpatient settings. Until data from such trials become available, where possible, it may be prudent to target an oxygen saturation at least at the upper end of the recommended 92–96% range in COVID-19 patients both in the inpatient and outpatient settings (in patients that are normoxemic at pre-COVID baseline). Home pulse oximetry, tele-monitoring, and earlier institution of oxygen supplementation for hypoxemic COVID-19 outpatients could be beneficial, where public health resources allow for their implementation. |
topic |
SARS-CoV-2 COVID-19 Hypoxemia Hypoxia ACE2 |
url |
http://link.springer.com/article/10.1186/s12916-020-01735-2 |
work_keys_str_mv |
AT nirajshenoy considerationsfortargetoxygensaturationincovid19patientsareweundershooting AT rebeccaluchtel considerationsfortargetoxygensaturationincovid19patientsareweundershooting AT permindergulani considerationsfortargetoxygensaturationincovid19patientsareweundershooting |
_version_ |
1724473026856091648 |